SDC4 and neoplasm: TN-C is considered to operate in the surrounding tumor microenvironment by binding to its receptor, annexin II [24, 25] or its co-receptor, syndecan-4/α5β 1[26–29], causing the loss of focal adhesions and mitogenesis, and increasing cell migration [30, 31].